Shouzhi Fu

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Yeming Wang, Dingyu Zhang, Guanhua Du et al. · The Lancet · 2020 · 3.7K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +4

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Peng Zhang, Lihua Zhu, Jingjing Cai et al. · Circulation Research · 2020 · 1.2K citations · Full text

Medicine, Cardiology, Internal Medicine +13

Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China

Fang Lei, Ye-Mao Liu, Feng Zhou et al. · Hepatology · 2020 · 448 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China

Jiqian Xu, Xiaobo Yang, Luyu Yang et al. · Critical Care · 2020 · 251 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +10

Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study

Yu Yuan, Dan Xu, Shouzhi Fu et al. · Critical Care · 2020 · 218 citations · Full text

Medicine, Infectious Diseases, Critical Care Medicine +6